The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

NCT06420154 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)
Sjogren's Syndrome
Systemic Sclerosis
Inflammatory Myopathy
ANCA Associated Vasculitis
Antiphospholipid Syndrome

Interventions

BIOLOGICAL: anti-CD19-CAR-T cells

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Collaborators

[object Object]